Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis
Background: Although with the application of etanercept biosimilars in the field of rheumatoid arthritis, the evidences of their efficacy, safety, and immunogenicity are still limited. We conducted this meta-analysis to evaluate the efficacy, safety and immunogenicity of etanercept biosimilars for t...
Saved in:
Main Authors: | Rui Hu (Author), Tao Yuan (Author), Hui Wang (Author), Jianglin Zhao (Author), Liya Shi (Author), Quankai Li (Author), Chunmei Zhu (Author), Na Su (Author), Shengzhao Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
by: Nuria Carballo, et al.
Published: (2022) -
Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
by: Qige Wei, et al.
Published: (2023) -
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
by: Stephanie F. Ling, et al.
Published: (2024) -
Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
by: Jian Cao, et al.
Published: (2019) -
EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2011)